Goal and Learning Outcomes

The goal of this program is to help providers in various practice settings distinguish life-threatening causes of low back pain from nonspecific, musculoskeletal presentations. After studying the information presented here, you will be able to:
  • Recognize the important anatomic and pathophysiologic components of low back pain
  • Identify red flag signs and symptoms in the history and physical exam that suggest potentially life-threatening pathology
  • Distinguish situations when emergent imaging studies are warranted from situations when it is best to take a conservative approach to management
  • Identify the importance of collaboration and communication among various healthcare providers, including physicians, nurses, and physical and occupational therapists
  • Recognize that a multidisciplinary approach is the key to treating acute and chronic low back pain

Course Authors

Accreditation Information


In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791



Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses


Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.



None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.